GlassScriptPhysician profile
Raj Shah
NPI 1215377981
$1,835.49
in general payments reported to CMS, 2019-2025
15 companies · $54.41 in 2025
The $54.41 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $85.59 · 2021: $99.74 · 2022: $294 · 2023: $1,060 · 2024: $34.53 · 2025: $54.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,149.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $986.68 | 2023 | Fujifilm |
| Medtronic, INC. | $358.59 | 2021-2024 | Ellipsys Vascular Access System, Kyphon Express II Kyphopak Tray |
| Angiodynamics, INC. | $129.93 | 2019-2024 | Alphavac, Micro Access |
| Apollo Endosurgery US INC | $78.97 | 2022 | |
| Becton, Dickinson and Company | $37.54 | 2019 | |
| Mimedx Group, INC. | $31.29 | 2025 | |
| Bard Peripheral Vascular, INC. | $28.86 | 2020 | |
| Ethicon US, LLC | $26.92 | 2019 | |
| Penumbra, INC. | $26.16 | 2022 | |
| Medtronic USA, INC. | $25.00 | 2020 | |
| Abbott Laboratories | $24.50 | 2019 | |
| Urgo Medical North America, LLC | $23.12 | 2025 | Urgok2 |
| Shockwave Medical, INC | $22.94 | 2019 | |
| Terumo Medical Corporation | $18.26 | 2019 | |
| Ekos Corporation | $16.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.